Working… Menu

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03655756
Recruitment Status : Completed
First Posted : August 31, 2018
Last Update Posted : February 23, 2021
H. Lee Moffitt Cancer Center and Research Institute
Information provided by (Responsible Party):
Morphogenesis, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 10, 2020
Actual Study Completion Date : December 4, 2020